Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1579, 2007-01, pp. : 22-22
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US FDA advises caution for recombinant erythropoietins
Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. :
Access to resources
Recommend
US FDA advises caution for recombinant erythropoietins
Reactions Weekly, Vol. 1, Iss. 1129, 2006-01 ,pp. :
US FDA reports new steps in drug safety
Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. :
The US FDA requires a "new vision of drug safety"
Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. :
Recombinant erythropoietins for renal anaemia: risks and rewards
Reactions Weekly, Vol. 1, Iss. 1131, 2006-01 ,pp. :